In contrast to cancer cell–specific targets (such as PSMA, HER-2, and SSTR), immune cell imaging faces the challenge of limited target-expressing cell densities, necessitating tracers with exceptional sensitivity and spatial resolution to achieve accurate detection. The gene discussed is ERBB2; the disease is cancer.